Om avsnittet
This Alma In Conversation addresses the current state of psychedelics in mental health, what today’s clinical landscape and legal frameworks look like, the ways that providers can integrate medication-assisted therapy into treatment plans, and what comes next. We were joined by Dr. Nico Grundmann, Alma member and founder of Brooklyn-based ketamine infusion clinic Ember Health, psychotherapist Rebecca Kronman, and psychologist and Yale University clinical research fellow Alex Belser. Alma founder and CEO Harry Ritter moderated the discussion. Alma In Conversation brings together experts in their field for an open discussion about themes and topics relevant to mental health care providers and their clients. Alma is a network of therapists, coaches, and wellness professionals dedicated to simplifying access to high-quality, affordable mental health care and a destination for people seeking care. To learn more, visit helloalma.com.
Senaste avsnitten
Systems of Oppression with Dr. James Wadley
Prioritizing Emotional Health with Lori Gottlieb
Addiction, Recovery, and the Role of the Provider
Navigating Election Stress
Teletherapy Readiness and Regulations
COVID–19 and Perspectives on Death
Managing Work Stress at Home with Guy Winch
Confronting the Trauma of COVID–19